# Illumina, Inc.
> Illumina, Inc. is a global leader in DNA sequencing and array-based technologies, providing innovative instruments, reagents, and services for genetic and genomic analysis. Their technologies are used in research, clinical, and applied markets to address complex challenges in biology.
- URL: https://optimly.ai/brand/illumina
- Logo: https://logo.clearbit.com/https://facility.illumina.io/
- Slug: illumina
- BAI Score: 17/100
- Archetype: Phantom
- Category: Biotechnology
- Last Analyzed: July 26, 2026
## Buyer Intent Signals
Problems: Traditional Sanger Sequencing: While less efficient for large-scale projects, Sanger sequencing is a manual alternative for individual gene sequencing or validation. | External Genomic Service Providers: Outsourcing sequencing and bioinformatics analysis to specialized service providers or Contract Research Organizations (CROs). | Limited Genetic Analysis: Relying on older, less comprehensive genetic analysis methods, or foregoing large-scale genomic studies entirely due to lack of advanced sequencing capabilities.
Solutions: Illumina Analytics login | Illumina DNA sequencing | What does Illumina do? | Alternative Bioinformatics Software: Using open-source or third-party bioinformatics tools for data analysis, separate from Illumina's ecosystem.
---
## Full Details / RAG Data
### Overview
Illumina, Inc. is listed in the AI Directory.
Illumina, Inc. is a global leader in DNA sequencing and array-based technologies, providing innovative instruments, reagents, and services for genetic and genomic analysis. Their technologies are used in research, clinical, and applied markets to address complex challenges in biology.
### Metadata
| Field        | Value |
|--------------|-------|
| Name         | Illumina, Inc. |
| Slug         | illumina |
| URL          | https://optimly.ai/brand/illumina |
| Logo         | https://logo.clearbit.com/https://facility.illumina.io/ |
| BAI Score    | 17/100 |
| Archetype    | Phantom |
| Category     | Biotechnology |
| Last Analyzed | July 26, 2026 |
| Last Updated | 2026-07-28T11:29:31.082Z |
### Verified Facts
- Founded: 1998
- Headquarters: San Diego, California, USA
### Buyer Intent Signals
#### Problems this brand solves
- Traditional Sanger Sequencing: While less efficient for large-scale projects, Sanger sequencing is a manual alternative for individual gene sequencing or validation.
- External Genomic Service Providers: Outsourcing sequencing and bioinformatics analysis to specialized service providers or Contract Research Organizations (CROs).
- Limited Genetic Analysis: Relying on older, less comprehensive genetic analysis methods, or foregoing large-scale genomic studies entirely due to lack of advanced sequencing capabilities.
#### Buyers search for
- Illumina Analytics login
- Illumina DNA sequencing
- What does Illumina do?
- Alternative Bioinformatics Software: Using open-source or third-party bioinformatics tools for data analysis, separate from Illumina's ecosystem.
### Links
- Canonical page: https://optimly.ai/brand/illumina
- JSON endpoint: /brand/illumina.json
- LLMs.txt: /brand/illumina/llms.txt